IDEAS home Printed from https://ideas.repec.org/a/bla/jorssc/v66y2017i1p201-224.html
   My bibliography  Save this article

Parametric dose standardization for optimizing two-agent combinations in a phase I–II trial with ordinal outcomes

Author

Listed:
  • Peter F. Thall
  • Hoang Q. Nguyen
  • Ralph G. Zinner

Abstract

No abstract is available for this item.

Suggested Citation

  • Peter F. Thall & Hoang Q. Nguyen & Ralph G. Zinner, 2017. "Parametric dose standardization for optimizing two-agent combinations in a phase I–II trial with ordinal outcomes," Journal of the Royal Statistical Society Series C, Royal Statistical Society, vol. 66(1), pages 201-224, January.
    • Handle: RePEc:bla:jorssc:v:66:y:2017:i:1:p:201-224
    as

    Download full text from publisher

    File URL: http://hdl.handle.net/10.1111/rssc.12162
    Download Restriction: Access to full text is restricted to subscribers.
    ---><---

    As the access to this document is restricted, you may want to search for a different version of it.

    References listed on IDEAS

    as
    1. Peter F. Thall & Aniko Szabo & Hoang Q. Nguyen & Catherine M. Amlie-Lefond & Osama O. Zaidat, 2011. "Optimizing the Concentration and Bolus of a Drug Delivered by Continuous Infusion," Biometrics, The International Biometric Society, vol. 67(4), pages 1638-1646, December.
    2. B. Nebiyou Bekele & Yu Shen, 2005. "A Bayesian Approach to Jointly Modeling Toxicity and Biomarker Expression in a Phase I/II Dose-Finding Trial," Biometrics, The International Biometric Society, vol. 61(2), pages 343-354, June.
    3. Peter F. Thall & John D. Cook, 2004. "Dose-Finding Based on Efficacy–Toxicity Trade-Offs," Biometrics, The International Biometric Society, vol. 60(3), pages 684-693, September.
    4. Mauro Gasparini & Jeffrey Eisele, 2000. "A Curve-Free Method for Phase I Clinical Trials," Biometrics, The International Biometric Society, vol. 56(2), pages 609-615, June.
    5. Nadine Houede & Peter F. Thall & Hoang Nguyen & Xavier Paoletti & Andrew Kramar, 2010. "Utility-Based Optimization of Combination Therapy Using Ordinal Toxicity and Efficacy in Phase I/II Trials," Biometrics, The International Biometric Society, vol. 66(2), pages 532-540, June.
    6. Satoshi Morita & Peter F. Thall & Peter Müller, 2008. "Determining the Effective Sample Size of a Parametric Prior," Biometrics, The International Biometric Society, vol. 64(2), pages 595-602, June.
    7. Peter F. Thall & Hoang Q. Nguyen & Sarah Zohar & Pierre Maton, 2014. "Optimizing Sedative Dose in Preterm Infants Undergoing Treatment for Respiratory Distress Syndrome," Journal of the American Statistical Association, Taylor & Francis Journals, vol. 109(507), pages 931-943, September.
    8. Guosheng Yin & Yisheng Li & Yuan Ji, 2006. "Bayesian Dose-Finding in Phase I/II Clinical Trials Using Toxicity and Efficacy Odds Ratios," Biometrics, The International Biometric Society, vol. 62(3), pages 777-787, September.
    9. Peter F. Thall & Hoang Q. Nguyen & Thomas M. Braun & Muzaffar H. Qazilbash, 2013. "Using Joint Utilities of the Times to Response and Toxicity to Adaptively Optimize Schedule–Dose Regimes," Biometrics, The International Biometric Society, vol. 69(3), pages 673-682, September.
    Full references (including those not matched with items on IDEAS)

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. Peter F. Thall & Aniko Szabo & Hoang Q. Nguyen & Catherine M. Amlie-Lefond & Osama O. Zaidat, 2011. "Optimizing the Concentration and Bolus of a Drug Delivered by Continuous Infusion," Biometrics, The International Biometric Society, vol. 67(4), pages 1638-1646, December.
    2. Ying Kuen Cheung, 2014. "Simple benchmark for complex dose finding studies," Biometrics, The International Biometric Society, vol. 70(2), pages 389-397, June.
    3. Ying Yuan & Guosheng Yin, 2009. "Bayesian dose finding by jointly modelling toxicity and efficacy as time‐to‐event outcomes," Journal of the Royal Statistical Society Series C, Royal Statistical Society, vol. 58(5), pages 719-736, December.
    4. Guosheng Yin & Yisheng Li & Yuan Ji, 2006. "Bayesian Dose-Finding in Phase I/II Clinical Trials Using Toxicity and Efficacy Odds Ratios," Biometrics, The International Biometric Society, vol. 62(3), pages 777-787, September.
    5. Drovandi, Christopher C. & McGree, James M. & Pettitt, Anthony N., 2013. "Sequential Monte Carlo for Bayesian sequentially designed experiments for discrete data," Computational Statistics & Data Analysis, Elsevier, vol. 57(1), pages 320-335.
    6. Thomas A. Murray & Peter F. Thall & Ying Yuan & Sarah McAvoy & Daniel R. Gomez, 2017. "Robust Treatment Comparison Based on Utilities of Semi-Competing Risks in Non-Small-Cell Lung Cancer," Journal of the American Statistical Association, Taylor & Francis Journals, vol. 112(517), pages 11-23, January.
    7. Emma Gerard & Sarah Zohar & Hoai‐Thu Thai & Christelle Lorenzato & Marie‐Karelle Riviere & Moreno Ursino, 2022. "Bayesian dose regimen assessment in early phase oncology incorporating pharmacokinetics and pharmacodynamics," Biometrics, The International Biometric Society, vol. 78(1), pages 300-312, March.
    8. Haitao Pan & Ping Huang & Zuoren Wang & Ling Wang & Chanjuan Li & Jielai Xia, 2013. "A Novel Bayesian Seamless Phase I/II Design," PLOS ONE, Public Library of Science, vol. 8(9), pages 1-6, September.
    9. Yuxi Tao & Junlin Liu & Zhihui Li & Jinguan Lin & Tao Lu & Fangrong Yan, 2013. "Dose-Finding Based on Bivariate Efficacy-Toxicity Outcome Using Archimedean Copula," PLOS ONE, Public Library of Science, vol. 8(11), pages 1-6, November.
    10. Shenghua Fan & Bee Leng Lee & Ying Lu, 2020. "A Curve-Free Bayesian Decision-Theoretic Design for Phase Ia/Ib Trials Considering Both Safety and Efficacy Outcomes," Statistics in Biosciences, Springer;International Chinese Statistical Association, vol. 12(2), pages 146-166, July.
    11. Peter F. Thall & Hoang Q. Nguyen & Thomas M. Braun & Muzaffar H. Qazilbash, 2013. "Using Joint Utilities of the Times to Response and Toxicity to Adaptively Optimize Schedule–Dose Regimes," Biometrics, The International Biometric Society, vol. 69(3), pages 673-682, September.
    12. Peter F. Thall & Hoang Q. Nguyen & Sarah Zohar & Pierre Maton, 2014. "Optimizing Sedative Dose in Preterm Infants Undergoing Treatment for Respiratory Distress Syndrome," Journal of the American Statistical Association, Taylor & Francis Journals, vol. 109(507), pages 931-943, September.
    13. Peter Müller & Don A. Berry & Andrew P. Grieve & Michael Krams, 2006. "A Bayesian Decision-Theoretic Dose-Finding Trial," Decision Analysis, INFORMS, vol. 3(4), pages 197-207, December.
    14. Peng Yang & Yuansong Zhao & Lei Nie & Jonathon Vallejo & Ying Yuan, 2023. "SAM: Self‐adapting mixture prior to dynamically borrow information from historical data in clinical trials," Biometrics, The International Biometric Society, vol. 79(4), pages 2857-2868, December.
    15. Roland Brown & Yingling Fan & Kirti Das & Julian Wolfson, 2021. "Iterated multisource exchangeability models for individualized inference with an application to mobile sensor data," Biometrics, The International Biometric Society, vol. 77(2), pages 401-412, June.
    16. Heinz Schmidli & Sandro Gsteiger & Satrajit Roychoudhury & Anthony O'Hagan & David Spiegelhalter & Beat Neuenschwander, 2014. "Robust meta-analytic-predictive priors in clinical trials with historical control information," Biometrics, The International Biometric Society, vol. 70(4), pages 1023-1032, December.
    17. Matthew Reimherr & Xiao‐Li Meng & Dan L. Nicolae, 2021. "Prior sample size extensions for assessing prior impact and prior‐likelihood discordance," Journal of the Royal Statistical Society Series B, Royal Statistical Society, vol. 83(3), pages 413-437, July.
    18. Egidi, Leonardo, 2022. "Effective sample size for a mixture prior," Statistics & Probability Letters, Elsevier, vol. 183(C).
    19. Chunyan Cai & Ying Yuan & Yuan Ji, 2014. "A Bayesian dose finding design for oncology clinical trials of combinational biological agents," Journal of the Royal Statistical Society Series C, Royal Statistical Society, vol. 63(1), pages 159-173, January.
    20. Ghaderinezhad, Fatemeh & Ley, Christophe & Serrien, Ben, 2022. "The Wasserstein Impact Measure (WIM): A practical tool for quantifying prior impact in Bayesian statistics," Computational Statistics & Data Analysis, Elsevier, vol. 174(C).

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:bla:jorssc:v:66:y:2017:i:1:p:201-224. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Wiley Content Delivery (email available below). General contact details of provider: https://edirc.repec.org/data/rssssea.html .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.